Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Recurrent Uterine Carcinosarcoma
NCT00075400Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2004
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in uterine carcinosarcoma (UCS), sponsored by National Cancer Institute. Started Jan 2004; status: completed.
02
Drugs
03
Conditions
uterine carcinosarcoma (UCS)
Beyond the preview
Go deeper on NCT00075400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075400.